Having problems with message search?
This event should interest some Future Saloners! Sudhi told me that since I'm sending this listing to the Future Salon list, you can sign up for the "Affiliates who advertise this event-$29" rate.
~Elise
From: Sudhi Gautam [mailto:sudhi@...]
'Convergence Of Intelligent Systems In Drug-Device Combinations –
The Shape Of Things To Come'
Since seating is limited to first 100, pl register early.
To register, visit: http://www.acteva.com/booking.cfm?bevaID=132654
Event details:
Event: Convergence Of Intelligent Systems In Drug-Device Combinations – The Shape Of Things To Come'
A drug-Device combination, the healthy marriage of medical devices withdrugs/biologics is an exciting new frontier with huge revenuepotential. It can revolutionize medical treatments and re-invigorateexisting drugs & devices while making current treatments obsolete.Combination products i.e., drug-device, drug-biologic, anddevice-biologic products, are increasingly incorporating cutting edge,novel technologies that hold great promise for advancing patient care.This new therapeutic modality is also rapidly narrowing the gap betweenPharma, Biologics and Devices. Combination products, a multi-billiondollar opportunity, are an area of intense interest and unlimitedpotential from a clinical as well as an investment point of view.
With the approval of Johnson & Johnson's Cypher drug-eluting stentand Boston Scientific's Taxus drug-eluting stent, drug-devicecombination products have attracted medical and media attention. Today,combination products range from drug-eluting stents for coronaryblockages, to drug-biological products, such as device-monoclonalantibodies for the treatment of cancer. Artificial organs and drugs onchips are other examples of such combination innovations.
How does it shape together?
In this event, our experienced panelists consisting of seasonedinvestors and entrepreneurs will brainstorm on the various aspects ofthe `combination world'. They will identify opportunities, hurdles, andregulatory challenges for the novel combination world and investorswill share what they are looking for in their next combinationinvestments. The event will help provide these converging industrieswith a roadmap for netherworld of – drugs, devices, and/or biologics.Come and bring your friends to get answers to questions like:
• What is a drug-device combination?
• What is the combination market potential?
• Does this have a significant effect on the way drugs and devices willbe developed in the future? Can `intelligence' be incorporated into thedrug-device combinations?
• What are the regulatory, technical, clinical and funding challenges involved?
• What is the key for a successful and rapid regulatory process for combination product?
• What does a `combination entrepreneur' look like?
• What are the possible Combination Product Strategies?
• What is a drug-device combination?
• What is the combination market potential?
• Does this have a significant effect on the way drugs and devices willbe developed in the future? Can `intelligence' be incorporated into thedrug-device combinations?
• What are the regulatory, technical, clinical and funding challenges involved?
• What is the key for a successful and rapid regulatory process for combination product?
• What does a `combination entrepreneur' look like?
• What are the possible Combination Product Strategies?
The Panel:
• Marc Galletti, Founder and Managing Director, Longitude Capital
• Vera Kallmeyer, MD, Ph.D., Founder+Managing Partner, Equity4health LLC
• Daniel Mufson, Ph.D., FAAPS, CSO, Circle Medical Devices
• Marc Galletti, Founder and Managing Director, Longitude Capital
• Vera Kallmeyer, MD, Ph.D., Founder+Managing Partner, Equity4health LLC
• Daniel Mufson, Ph.D., FAAPS, CSO, Circle Medical Devices
Moderator: Frank Rahmani, Partner, Cooley Godward Kronish LLP
WHEN: Thursday, May 17
6:00 - 7:00 pm: Networking and Business Showcase
7:00 - 8:15 pm: Panel discussion and Q/A
8:15 - 8:30 pm: Additional networking
6:00 - 7:00 pm: Networking and Business Showcase
7:00 - 8:15 pm: Panel discussion and Q/A
8:15 - 8:30 pm: Additional networking
LOCATION:
Cooley Godward Kronish LLP, 3175 Hanover Street, Palo Alto, CA 94304
Cooley Godward Kronish LLP, 3175 Hanover Street, Palo Alto, CA 94304
PRE-REGISTERED RATES (All Rates Include Hors D'oeuvres):
Members - $20; Affiliates who advertise this event-$29; Gen Public - $49;
Biz Showcase Exhibit Table - $149 (Includes exhibit table +2 tickets)
Members - $20; Affiliates who advertise this event-$29; Gen Public - $49;
Biz Showcase Exhibit Table - $149 (Includes exhibit table +2 tickets)
WALK-IN RATES: Add $10.00 to the listed price
Seating is limited, so early registration is recommended to avoid disappointment.
Offline 
Send Email